VEGF Mechanism

NewsGuard 100/100 Score

VEGF or vascular endothelial growth factor is a signalling protein made by cells that stimulates the formation of new blood vessels. There are several different classes of VEGF that play different roles in the body, both in normal bodily process and pathological processes.

VEGF proteins form a particular sub-family of growth factors referred to as the platelet-derived growth factor family of cystine-knot growth factors. They are key signalling proteins involved in two different types of blood vessel formation, namely vasculogenesis and angiogenesis. Vasculogenesis refers to the de novo formation of vessels during development of the embryo’s circulatory system, while angiogenesis describes the formation of blood vessels from vasculature that already exists.

VEGF is made by various different types of cells including macrophages, keratinocytes, tumor cells, platelets, and mesangial cells in the kidney. As well as promoting the formation of blood and lymph vessels, VEGF plays a role in the formation of bones and blood, as well as being required for wound healing and embryonic development.

VEGF proteins promote cellular responses when they bind to tyrosine kinase receptors or VEGF receptors. These VEGF receptors lie on the cell surface and when VEGF binds to them, they undergo dimerization and transphosphorylation to become activated. This activation process occurs at various different sites, at different times and to different extents. The VEGF receptor is made up of an extracellular portion comprising 7 immunoglobulin-like domains, a transmembrane spanning portion and an intracellular portion that contains a split tyrosine-kinase domain.

One of the most important members of the VEGF family, VEGF-A, binds to the receptors - VEGFR-1 and VEGFR-2. VEGFR-2 is thought to mediate most of the cellular responses to VEGF. The function of VEGFR-1, however, is less clear, but this receptor seems to modulate VEGFR-2 signalling. VEGFR-1 also acts as a dummy/decoy receptor that can sequester the VEGF from VEGFR-2 binding. This process is important when blood vessels are developing in the embryo. VEGF-C and VEGF-D can bind exclusively to a third receptor, VEGFR-3, which mediates the formation of lymphatic capillaries.

Further Reading

Last Updated: Aug 18, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, August 18). VEGF Mechanism. News-Medical. Retrieved on May 25, 2024 from

  • MLA

    Mandal, Ananya. "VEGF Mechanism". News-Medical. 25 May 2024. <>.

  • Chicago

    Mandal, Ananya. "VEGF Mechanism". News-Medical. (accessed May 25, 2024).

  • Harvard

    Mandal, Ananya. 2023. VEGF Mechanism. News-Medical, viewed 25 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment